Novartis's Falcon 7X lands in Newark after an unusual departure from a French airfield

The flight from LFFN is unusual. Brienne-le-Château is a former military airfield now used for general aviation and light industry. It is not a known Novartis maintenance or operations site. The aircraft's recent movements show it had been shuttling between Italy and Basel in the days prior — on August 21 it flew from a point near Rome to Basel, then back to Rome. The hop to LFFN and then directly to Newark suggests a possible crew change, a pickup of personnel or materials, or a repositioning after a European trip. The broader pattern holds: HB-JFQ has logged extensive transatlantic crossings this year, including a Basel-to-San Francisco leg on June 28 and a Newark-to-Indianapolis-to-Basel run on August 13.

Novartis's aviation footprint is expanding. In April 2026, ch-aviation reported that the company added its first Dassault Falcon 8X, a newer and longer-range model, to the fleet managed by Japat AG. The three existing Falcon 7X jets — HB-JFQ, HB-JFR, and HB-JFS — remain the workhorses for connecting Basel with pharmaceutical hubs in the US, Europe, and Asia. Private aviation allows Novartis to move executives rapidly between research centers, manufacturing sites, and regulatory meetings — a necessity when trade policy can shift overnight.

Whether this particular flight carried the CEO or a logistics team, the timing places Novartis's aircraft in the New York region at a moment when the company's US supply chain and tariff exposure remain live issues. The aircraft's next move will tell the rest of the story.